BCR-ABL 基因 ; 费城染色体 ; 融合蛋白 ; 白质
bcr abl mrna 细胞bcrablmrna
bcr abl fusion gene bcrabl融合基因
bcr-abl fusion gene bcrabl融合基因
But Gleevac, too, can be bypassed by further mutations of BCR-ABL which allow the tumour cells to grow in the presence of the drug.
但它无法阻止BCR - ABL产生进一步变异后的编码蛋白,即使在用药情况下肿瘤细胞仍不断扩张。
There is already a targeted treatment for this disease. Gleevec, probably the most remarkable anti-cancer drug of the past decade, disables the protein encoded by another fused gene, BCR-ABL.
现在对这种病已有针对性疗法,Gleevec大体是过去十年中效果最显著的药物,它能使另一融合基因BCR-ABL的编码蛋白失去活性。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).
目的:探讨慢性粒细胞白血病(CML)患者BCR/ABL融合基因表达与中医辨证分型的关系。
应用推荐